Epstein–Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin
2009 ◽
Vol 160
(1)
◽
pp. 205-207
◽
Keyword(s):
2020 ◽
Vol 61
(9)
◽
pp. 2250-2253
◽
2012 ◽
Vol 54
(6)
◽
pp. 1201-1207
◽
Keyword(s):